Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Calidi Biotherapeutics
(AMEX:CLDI)
Intraday
$0.2336
0.0078
[3.45%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.2336
0.0078
[3.45%]
At close: May 15
Get Report
Watch
Q1 2024 Earnings were released on Tue May 14th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Calidi Biotherapeutics Stock (AMEX:CLDI)
Calidi Biotherapeutics Stock (AMEX: CLDI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 15, 2024
Baird Maintains Outperform on Calidi Biotherapeutics, Lowers Price Target to $2
Benzinga Newsdesk
-
13 hours ago
Tuesday, May 14, 2024
Calidi Biotherapeutics Q1 2024 Adj EPS $(0.20) Beats $(0.28) Estimate
Benzinga Newsdesk
-
1 day ago
Monday, May 13, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
2 days ago
Monday, April 29, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Apr 29, 2024, 12:31PM
Tuesday, April 23, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Apr 23, 2024, 4:31PM
Friday, April 19, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Apr 19, 2024, 4:31PM
Tuesday, April 16, 2024
S&P 500 Edges Lower; PacBio Shares Plunge
Avi Kapoor
-
Apr 16, 2024, 2:30PM
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Apr 16, 2024, 2:17PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Apr 16, 2024, 12:31PM
Gold Moves Higher; Morgan Stanley Earnings Top Views
Avi Kapoor
-
Apr 16, 2024, 12:11PM
Why Calidi Biotherapeutics (CLDI) Shares Are Down Over 50%
Henry Khederian
-
Apr 16, 2024, 11:48AM
Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit
Avi Kapoor
-
Apr 16, 2024, 9:48AM
Calidi Biotherapeutics shares are trading lower after the company announced the pricing of a $6.1 million public offering.
Benzinga Newsdesk
-
Apr 16, 2024, 9:06AM
Calidi Biotherapeutics Announces Pricing Of $6.1M Public Offering
Benzinga Newsdesk
-
Apr 16, 2024, 8:33AM
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 16, 2024, 8:14AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Apr 16, 2024, 8:07AM
Tuesday, April 09, 2024
Calidi Biotherapeutics Presents New Data On Mechanisms Of Action For Virotherapy-loaded Stem Cells Used In The Company's Immunotherapies At AACR Annual Meeting 2024
Benzinga Newsdesk
-
Apr 9, 2024, 7:12AM
Thursday, March 21, 2024
Baird Maintains Outperform on Calidi Biotherapeutics, Lowers Price Target to $4.5
Benzinga Newsdesk
-
Mar 21, 2024, 1:57PM
HC Wainwright & Co. Maintains Buy on Calidi Biotherapeutics, Lowers Price Target to $2
Benzinga Newsdesk
-
Mar 21, 2024, 8:54AM
Friday, March 15, 2024
Calidi Biotherapeutics Q4 EPS $(0.23) Misses $(0.20) Estimate
Happy Mohamed
-
Mar 15, 2024, 4:11PM
Monday, March 11, 2024
Calidi Biotherapeutics And City Of Hope Announce Funding Of $5.3M From The California Institute For Regenerative Medicine To Advance CLD-101 (Neuronova) In Ovarian Cancer
Benzinga Newsdesk
-
Mar 11, 2024, 7:18AM
Tuesday, February 27, 2024
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Feb 27, 2024, 1:18PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Feb 27, 2024, 12:31PM
Friday, February 23, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Feb 23, 2024, 12:31PM
Thursday, February 22, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Feb 22, 2024, 12:31PM
Monday, February 19, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Feb 19, 2024, 8:05AM
Monday, February 12, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Feb 12, 2024, 4:30PM
Calidi Biotherapeutics Reports Upcoming Presentation To Provide Details On Development Of Systemic Enveloped Oncolytic Virotherapy Platform
Benzinga Newsdesk
-
Feb 12, 2024, 7:12AM
Tuesday, January 30, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jan 30, 2024, 8:05AM
Monday, January 22, 2024
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Jan 22, 2024, 1:08PM
Tuesday, January 09, 2024
Why Juniper Networks Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 9, 2024, 8:23AM
Wednesday, January 03, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Jan 3, 2024, 8:05AM
Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 3, 2024, 7:59AM
Wednesday, December 13, 2023
Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the Oncolytic Virotherapy Summit; Company Will Also Share Progress With Cell-based Virotherapy Platforms For Advanced Solid Tumors
Benzinga Newsdesk
-
Dec 13, 2023, 7:05AM
Wednesday, November 22, 2023
HC Wainwright & Co. Initiates Coverage On Calidi Biotherapeutics with Buy Rating, Announces Price Target of $11
Benzinga Newsdesk
-
Nov 22, 2023, 6:26AM
Monday, November 20, 2023
Calidi Biotherapeutics Announces Issuance Of New US Patent Covering Novel SuperNova Technology Platform
Benzinga Newsdesk
-
Nov 20, 2023, 7:05AM
Tuesday, November 14, 2023
Calidi Biotherapeutics Q3 EPS $(0.14) Up From $(0.63) YoY
Benzinga Newsdesk
-
Nov 14, 2023, 4:35PM
Monday, October 30, 2023
Calidi Biotherapeutics Said On October 25, Entered Into Employment Agreement With Andrew Jackson To Serve As CFO Effective October 30
Charles Gross
-
Oct 30, 2023, 6:36AM
Monday, October 09, 2023
Analyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player
Vandana Singh
-
Oct 9, 2023, 2:21PM
Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023
Benzinga Insights
-
Oct 9, 2023, 11:00AM
Baird Initiates Coverage On Calidi Biotherapeutics with Outperform Rating, Announces Price Target of $9
Benzinga Newsdesk
-
Oct 9, 2023, 5:08AM
Monday, September 25, 2023
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Sep 25, 2023, 1:04PM
Friday, September 22, 2023
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Sep 22, 2023, 2:22PM
Wednesday, September 20, 2023
Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Sep 20, 2023, 2:10PM
Wednesday, September 13, 2023
Dow Turns Lower; KULR Technology Group Shares Plummet
Lisa Levin
-
Sep 13, 2023, 3:05PM
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Sep 13, 2023, 2:07PM
Dow Gains 50 Points; US Crude Oil Inventories Rise
Lisa Levin
-
Sep 13, 2023, 12:01PM
Nasdaq Gains 50 Points; US Inflation Rate Rises In August
Lisa Levin
-
Sep 13, 2023, 9:51AM
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch